Encephalitis, Japanese: all 77 studies

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
• Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis VirusNot yet recruitingNCT06674837
• Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine ImmunogenicityRecruitingNCT06027801Not applicable
• An Experimental Medicine Decipher of a Minimum Correlate of Cellular ImmunityRecruitingNCT05568953Phase 2
• Flavivirus Cross-priming Potential of IMOJEVCompletedNCT03920111Not applicableResults posted
• Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) VaccineCompletedNCT02880865Phase 4Results posted
• Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster DoseCompletedNCT02514746Phase 4Results posted
• Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy SubjectsCompletedNCT02492165Phase 3Results posted
• Post-licensure Safety Study of IMOJEV® in ThailandCompletedNCT01981967Phase 4Results posted
• Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South KoreaCompletedNCT01900444Phase 3Results posted
• Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult SubjectsCompletedNCT01662440Phase 3Results posted
• A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2CompletedNCT01656200Phase 4Results posted
• Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 VaccineCompletedNCT01567865Phase 4Results posted
• A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3Results posted
• Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai ChildrenCompletedNCT01408537Phase 3Results posted
• Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in ToddlersCompletedNCT01396512Phase 3Results posted
• Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic CountryCompletedNCT01296360Phase 3Results posted
• Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-StudyCompletedNCT01246479Phase 3Results posted
• Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CVCompletedNCT01190228Phase 3Results posted
• Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3Results posted
• A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and ToddlersCompletedNCT01092507Phase 3Results posted
• Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic CountriesCompletedNCT01047839Phase 3Results posted
• Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric PopulationCompletedNCT01041573Phase 3Results posted
• Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ToddlersCompletedNCT01001988Phase 3Results posted
• Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)CompletedNCT00982137Phase 2Results posted
• Study of Live Attenuated ChimeriVax™-Japanese Encephalitis VaccineCompletedNCT00981630Phase 2Results posted
• A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy AdultsCompletedNCT00981175Phase 2Results posted
• Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post FillingCompletedNCT00776230Phase 3Results posted
• Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the PhilippinesCompletedNCT00735644Phase 3Results posted
• Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildrenCompletedNCT00621764Phase 2Results posted
• Safety and Tolerability of the Japanese Encephalitis Vaccine IC51CompletedNCT00605085Phase 3Results posted
• Immunogenicity Study of the Japanese Encephalitis Vaccine IC51CompletedNCT00604708Phase 3Results posted
• Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440CompletedNCT00596271Phase 3Results posted
• Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51CompletedNCT00596102Results posted
• Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51CompletedNCT00595790Phase 3Results posted
• Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51CompletedNCT00595465Phase 3Results posted
• Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51CompletedNCT00595309Phase 3Results posted
• Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51CompletedNCT00595270Phase 3Results posted
• Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51CompletedNCT00594958Phase 3Results posted
• Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of AgeCompletedNCT00463684Phase 4Results posted
• Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE VaccineCompletedNCT00463476Phase 4Results posted
• Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending AgeCompletedNCT00441259Phase 2Results posted
• Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles VaccineCompletedNCT00412516Phase 3Results posted
• A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAXCompletedNCT00319592Phase 2Results posted
• A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAXCompletedNCT00314145Phase 3Results posted
• Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.CompletedNCT00314132Phase 3Results posted
• Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles VaccineCompletedNCT00249769Phase 3Results posted
• A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsCompletedNCT06680128Phase 1/2
• Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence AreasActive, not recruitingNCT06678373Phase 4
• Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary ImmunizationCompletedNCT06372665
• Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)CompletedNCT06331702Phase 4
• Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang ProvinceStatus unknownNCT04817917Phase 4
• Purified Inactivated Japanese Encephalitis VaccineStatus unknownNCT04223037Phase 3
• Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.Status unknownNCT03971058Phase 4
• Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in VietnamCompletedNCT03282370Phase 3
• Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of AgeCompletedNCT03204227Phase 2
• Postmarketing Surveillance Study for IMOJEV® in Republic of KoreaCompletedNCT02933710
• Safety and Immunogenicity of JECEVAX in Young ChildrenCompletedNCT02816554Phase 2
• Immunogenicity of Co-administration of Measles and Japanese Encephalitis VaccinesCompletedNCT02643433Phase 4
• Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 VaccineCompletedNCT02602652Not applicable
• Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis VaccineinjCompletedNCT02532569Phase 4
• A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese InfantsCompletedNCT02367664Phase 3
• 6-year Antibody Check After Third Vaccination Against Japanese EncephalitisCompletedNCT02039440Phase 4
• Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ChildrenStatus unknownNCT01954810Phase 4
• The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansCompletedNCT01943305Phase 2
• Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese EncephalitisCompletedNCT01856205Phase 2
• Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineCompletedNCT01815073Phase 4
• Immune Response in IXIARO Batch JEV09L37 Recipients Before and After RevaccinationWithdrawnNCT01559831Phase 1
• Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis VaccineCompletedNCT01398540Phase 4
• Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese EncephalitisCompletedNCT01386827Phase 3
• Safety Surveillance After Immunization With IXIAROCompletedNCT01335412
• Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, TaiwanStatus unknownNCT01163123
• This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly PopulationCompletedNCT01158599Phase 4
• Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in KoreaCompletedNCT01150942Phase 3
• Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRStatus unknownNCT00938379Phase 3
• Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in ToddlersCompletedNCT00694460Phase 2
• Treatment of Japanese EncephalitisStatus unknownNCT00216268Phase 2

← Encephalitis, Japanese overview